Effects of Pulsing Procedure of Interleukin-12 in Combination with Interleukin-2 on the Activation of Peripheral Blood Lymphocytes Derived from Patients with Hepatocellular Carcinoma

Acta Medica Okayama

Volumn 57, Issue 6, 2003, Pages 285-292

  Sawayama, Tomoyuki ^a   Sakaguchi, Kohsaku ^a   Senoh, Tomonori ^a   Ohta, Takeyuki ^a   Nishimura, Mamoru ^a   Takaki, Akinobu ^a   Tsuji, Takao ^a   Shiratori, Yasushi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Granzyme B; Hepatocellular carcinoma (HCC); Interferon (IFN) ; Interleukin (IL) 12; Interleukin (IL) 2

Indexed keywords

GAMMA INTERFERON; GRANZYME B; MESSENGER RNA; PERFORIN; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GRANZYMES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; PORE FORMING CYTOTOXIC PROTEINS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0942300581     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Seki T, Nonaka T, Kubota Y, Mizuno T and Sameshima Y: Ultrasonically guided percutaneous ethanol injection therapy for hepatocellular carcinoma. Am J Gastroenterol (1989) 84: 1400-1407.
2. Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, Garbagnati F and Buscarini L: Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am (1995) 1: 73.
3. Goldberg SN, Gazelle GS, Compton CC, Mueller PR and Tanabe KK: Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation. Cancer (2000) 88: 2452-2463.
4. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K and Takashima S: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 148: 397-401.
5. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Arai K, Demachi H, Miyayama S, Takashima T, Unoura M and Kobayashi K: Small hepatocellular carcinoma: Treatment with subsegmental transcatherter arterial embolization. Radiology (1993) 188: 79-83.
6. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J and Bruix J: Barcelona Liver Cancer Group: Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet (2002) 359: 1734-1739.
7. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T and Yukaya H: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology (1993) 105: 488-494.
8. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL and Pigato P: Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: Results in a series of 100 Italian patients. Cancer (1998) 82: 1028-1036.
9. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N and Muto T: Surgical resection for small hepatocellular carcinoma. Surgery (1996) 119: 40-45.
10. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON, Taniura H and Uchida M: Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg (2001) 88: 515-522.
11. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T and Sugimachi K: Natural killer cell activity in patients with hepatocellular carcinoma: A new prognostic indicator after hepatectomy. Cancer (1998) 83: 58-63.
12. Kawarabayashi N, Seki S, Hatsuse K, Ohkawa T, Koike Y, Aihara T, Habu Y, Nakagawa R, Ami K, Hiraide H and Mochizuki H: Decrease CD56(+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology (2000) 32: 962-969.
13. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C and Hewick RM: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol (1991) 146: 3074-3081.
14. Trinchieri G: Interleukin 12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type I and cytotoxic lymphocytes. Blood (1994) 84: 4008-4027.
15. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SG and Trinchieri G: Induction of IFN-γ production by NK cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 173: 869-879.
16. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y and Kakizoe T: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomized trial. Lancet (2000) 356: 802-807.
17. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D and Nickbarg E: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 175: 789-796.
18. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH and Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 175: 779-788.
19. Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI and Sugimachi K: Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res (2001) 61: 1005-1012.
20. Barajas M, Mazzolini G, Genove G, Bilbao R, Narvaiza I, Schmitz V, Sangro B, Melero I, Qian C and Prieto J: Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interkeukin 12. Hepatology (2001) 33: 52-61.
21. Chan SH, Kobayashi M, Santoli D, Perussia B and Trinchieri G: Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol (1992) 148: 92-98.
22. Ye J, Ortaldo JR, Conlon K, Winkler-Pickett R and Young HA: Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol (1995) 58: 225-233.